Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic

Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic

Abstract As of today, there is no antiviral for the treatment of the SARS-CoV-2 infection, and the development of a vaccine might take several months or even years. The structural superposition of the hepatitis C virus polymerase bound to sofosbuvir, a nucleoside analog antiviral approved for hepati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rodrigo Jácome, José Alberto Campillo-Balderas, Samuel Ponce de León, Arturo Becerra, Antonio Lazcano
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/27f5e92cc72e48598ae0a79c08b15f67
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares